ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/22/2025
Back to search
Official data from USPTO
DEBIOPHARM GROUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000077202066Class
35, 42, 44, 45
Filing
77202066
Registration
3735602
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
06/23/2025
Trademark type
Combined
Nice classes
35, 42, 44, 45
Filing date
06/08/2007
Registration date
01/12/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2020
Last transaction
06/23/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
33
Owner location
LAUSANNE, CH
Examiner
MORRIS, KRISTINA
Law office
M70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a black lettered "Debiopharm" to the right of a solid red circle with white dot inside, and a gray lettered "Group" to the right of "Debiopharm".
Holders and representatives
Holders
APR�S-DEMAIN SA
APRES-DEMAIN HOLDING SA
DEBIOPHARM S.A.
Representatives
Duane M. Byers NIXON & VANDERHYE, P.C.
Technical classification
Nice Classes
Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertising; business management; business administration; office functions; advertisingproviding declarations or announcements referring to services or information concerning pharmaceutical or veterinary productsinvestmentslicensing in and out agreements of all types in connection with pharmaceutical or veterinary products ; providing consumer product information relating to pharmaceuticals
Class 42
Scientific research and development; development of products in the scientificbiologicalmedical and pharmaceutical fields
Class 44
Providing medical information and medical information relating to pharmaceutical products
Class 45
Legal services pertaining to the acquisition and/or concession of licenses in scientificbiologicalmedical and pharmaceutical fields
Publications
History of USPTO decisions and trademark events.
59 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/22/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/18/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/01/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/01/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/31/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/10/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
05/31/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/12/2019
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
09/17/2016
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/15/2016
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
05/18/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/13/2016
WDRL
OTQR WITHDRAWAL FROM PUBLICATION
05/06/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/22/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/22/2016
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
04/22/2016
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/11/2016
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
02/16/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/16/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/04/2016
E815
TEAS SECTION 8 & 15 RECEIVED
01/12/2016
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/12/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
01/12/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/27/2009
PUBO
PUBLISHED FOR OPPOSITION
10/27/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/22/2009
ALIE
ASSIGNED TO LIE
09/22/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/21/2009
DOCK
ASSIGNED TO EXAMINER
09/11/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/05/2009
GNRT
NON-FINAL ACTION E-MAILED
05/05/2009
CNRT
NON-FINAL ACTION WRITTEN
05/05/2009
DOCK
ASSIGNED TO EXAMINER
03/11/2009
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/13/2009
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/10/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/30/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2008
ALIE
ASSIGNED TO LIE
10/25/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/10/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/11/2008
GNRT
NON-FINAL ACTION E-MAILED
04/11/2008
CNRT
NON-FINAL ACTION WRITTEN
04/11/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2008
DOCK
ASSIGNED TO EXAMINER
11/14/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/06/2007
GNRT
NON-FINAL ACTION E-MAILED
08/06/2007
CNRT
NON-FINAL ACTION WRITTEN
08/06/2007
DOCK
ASSIGNED TO EXAMINER
08/04/2007
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
06/14/2007
NWAP
NEW APPLICATION ENTERED
06/13/2007
Continuous trademark protection
Get notified about every new filing that threatens DEBIOPHARM GROUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.